BIOGEN INC. Executive Compensation

Named executive officer pay as disclosed in the company’s 2025-04-28 proxy statement (SEC Form DEF 14A). Figures are total annual compensation for the most recent fiscal year reported.

$24,166,665

Christopher A. Viehbacher, Chief Executive Officer — total compensation

$1,600,000

base salary

Healthcare

industry

Executive	Title	Base salary	Total compensation
Christopher A. Viehbacher	President and CEO	$1,600,000	$24,166,665
Priya A. Singhal	Head of Development	$816,346	$6,387,663

Source: BIOGEN INC. Definitive Proxy Statement (DEF 14A), filed 2025-04-28 with the U.S. Securities and Exchange Commission. View the filing on SEC.gov. Total compensation reflects the Summary Compensation Table and includes salary, bonus, stock and option awards, non-equity incentive pay, and all other compensation as defined by SEC rules.